These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6621466)

  • 21. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibody against synthetic peptide corresponding to alpha-subunit residues 128-142 of nicotinic acetylcholine receptor (AChR): the significance in myasthenia gravis (MG)].
    Shibuya N; Kanazawa H; Uyemura K
    Rinsho Shinkeigaku; 1988 Mar; 28(3):315-9. PubMed ID: 3402139
    [No Abstract]   [Full Text] [Related]  

  • 23. A solid-phase enzyme immunoassay for anti-acetylcholine receptor antibody in myasthenia gravis patients.
    Kobayashi N; Sugita H; Terada E; Ghoda A; Okudaira H; Ogita T; Miyamoto T
    J Immunol Methods; 1984 Oct; 73(2):267-72. PubMed ID: 6386990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detection in myasthenia gravis.
    Mirian A; Nicolle MW; Edmond P; Budhram A
    J Neurol Sci; 2022 Jan; 432():120084. PubMed ID: 34906880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-AChR-negative myasthenia gravis: clinical and immunological features.
    Evoli A; Bartoccioni E; Batocchi AP; Scuderi F; Tonali P
    Clin Invest Med; 1989 Apr; 12(2):104-9. PubMed ID: 2706833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravis.
    Savage-Marengo T; Harrison R; Lunt GG; Behan PO
    J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):316-20. PubMed ID: 7373331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671.
    Voltz R; Hohlfeld R; Fateh-Moghadam A; Witt TN; Wick M; Reimers C; Siegele B; Wekerle H
    Neurology; 1991 Nov; 41(11):1836-8. PubMed ID: 1944918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodies.
    Thorlacius S; Lefvert AK; Aarli JA; Gilhus NE; Halvorsen K; Hofstad H; Matre R; Tönder O
    Acta Neurol Scand; 1986 Dec; 74(6):486-90. PubMed ID: 3825504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
    Hurst RL; Gooch CL
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):61. PubMed ID: 27170368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison and standardization of measurement of anti-acetylcholine receptor antibody between laboratories.
    Bonifacio E; Cobain TJ; Dawkins RL; Griffiths M; Kalden JR; Peter JB; Tindall RS; Vincent A
    Autoimmunity; 1988; 1(1):59-66. PubMed ID: 2979606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between myasthenia gravis-activities of daily living (MG-ADL) and quantitative myasthenia gravis (QMG) assessments of anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis in the phase 3 regain study.
    Vissing J; O'Brien F; Wang JJ; Howard JF
    Muscle Nerve; 2018 Aug; 58(2):E21-E22. PubMed ID: 29684239
    [No Abstract]   [Full Text] [Related]  

  • 33. Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis.
    Heilbronn E; Lefvert AK; Stålberg E
    Muscle Nerve; 1978; 1(5):427-31. PubMed ID: 263985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of human skeletal muscle acetylcholine receptor antibodies using monkey receptors.
    Mickle DA; Wong PY; Humphrey JG; Griffith K; Mee AV
    Clin Biochem; 1983 Jun; 16(3):163-6. PubMed ID: 6851078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.
    Vincent A; Newsom-Davis J; Newton P; Beck N
    Neurology; 1983 Oct; 33(10):1276-82. PubMed ID: 6684222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in 'antibody-negative' myasthenia gravis.
    Brooks EB; Pachner AR; Drachman DB; Kantor FS
    J Neuroimmunol; 1990 Jun; 28(1):83-93. PubMed ID: 2341562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic significance of autoantibodies to the acetylcholine receptor.
    Garlepp MJ; Kay PH; Dawkins RL
    J Neuroimmunol; 1982 Dec; 3(4):337-50. PubMed ID: 7174785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic sensitivity of the laboratory tests in myasthenia gravis.
    Oh SJ; Kim DE; Kuruoglu R; Bradley RJ; Dwyer D
    Muscle Nerve; 1992 Jun; 15(6):720-4. PubMed ID: 1324429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenia gravis. Anti-acetylcholine receptor antibodies.
    Cerrato D; Ariano C; La Mantia L; Fiacchino F; Sghirlanzoni A; Nespolo A; Corridori F; Cornelio F
    Ital J Neurol Sci; 1981 May; 2(2):165-71. PubMed ID: 7333817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [AChR Antibody-Positive Myasthenia Gravis].
    Murai H
    Brain Nerve; 2024 May; 76(5):613-620. PubMed ID: 38741504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.